Since NuVision was founded in 2015, we have been fortunate to grow relationships with a range of investors to aid the development of our portfolio of ocular biotherapies. 

Our aim is to ensure no patient goes without immediate access to treatment.

Our institutional investors

Get in touch

If you are interested in investing in our story, please submit your details below or contact: